Sulfanilamide — Active Pharmaceutical Ingredient

Sulfanilamide is an active pharmaceutical ingredient found in 2 FDA-approved drug products. Forms: CREAM, SUPPOSITORY. Routes: VAGINAL.

This content is for informational purposes only. Always consult a healthcare professional.

Sulfanilamide (2 brand names, 2 dosage forms, 1 route)

Available dosage forms: CREAM, SUPPOSITORY.

Routes of administration: VAGINAL.

Brand Names

  • AVC
  • SULFANILAMIDE

Dosage and Administration

Apply topically to sufficiently cover the open wound. Application every 2 to 3 days may be needed for larger superficial or deep wounds. Apply until granulation tissue has formed and evidence of healing is apparent.

Contraindications

Sulfonamides are contraindicated in animals that are hypersensitive to them and in animals with severe renal or hepatic impairment.

Warnings and Precautions

Withdrawal Periods and Residue Warnings Treated animals must not be slaughtered for human consumption within 28 days of the last treatment. A milk discard time has not been established for this product; do not use in animals producing milk for human consumption. A withdrawal period has not been established for this product in pre-ruminating calves; treated calves and calves born to treated cows must not be processed for veal.

Adverse Reactions

Clinical signs in veterinary species associated with organophosphate and carbamate toxicity include frequent urination and defecation, muscle twitching, and watering eyes, followed by salivation, diarrhea, vomiting, and muscle weakness. This can proceed to anorexia, miosis or mydriasis, dyspnea, and bradycardia or tachycardia, and can also include more rapid involuntary muscle twitching and scattered fasciculations, followed by severe weakness and paralysis.

⚠ Caution
Medical Disclaimer: This information is for educational purposes only. Always consult a healthcare professional before taking any medication.